latest update:
[TrialBase DB]

trial summary · NCT06801223

A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

A Multicenter, Open-label, Phase 1b Study to Assess the Pharmacokinetics, Safety, and Tolerability of Sulbactam-Durlobactam in Hospitalized Pediatric Patients From Birth to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Acinetobacter Baumannii-calcoaceticus Complex Infection

Trial record from the TrialBase DB dataset, status RECRUITING, condition Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC), sponsored by Innoviva Specialty Therapeutics. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT06801223phase PHASE1enrollment 48start 2026-12-30

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The goal of this clinical trial is to investigate the use of Sulbactam-Durlobactam (SUL-DUR) in pediatric patients and is being conducted to collect pharmacokinetic (PK) and safety data to enable the identification of appropriate pediatric dosing regimens for patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections

Source record: https://clinicaltrials.gov/study/NCT06801223

Facts

registry idNCT06801223
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE1
study typeINTERVENTIONAL
lead conditionAcinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
sponsorInnoviva Specialty Therapeutics
sponsor classINDUSTRY
enrollment48
start date2026-12-30
primary completion2028-05-05
completion2028-05-20
results postednot reported

Conditions

  • Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)

Interventions

  • Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours)
  • Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours)
  • Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours)
  • Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours)

Countries

  • United States

Intervention types: DRUG

Work with this record